Company intelligence / Profile preview
Sanna Science
- Ownership
- Private
- Development stage
- Other
Overview
Sanna Science is a UK-based biotech company developing clinically validated, prescription-grade cannabinoid medicines. Its lead candidate, Sanna Sleep, is a cannabinoid-based formulation targeting insomnia and sleep quality, with published pilot clinical results showing statistically significant improvements in sleep metrics[9]. Phase 1b and PK clinical trials are being conducted in collaboration with academic partners.
- Therapeutic areas
- NeurologyPsychiatry
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Sanna Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanna Science.